Adjuvant chest wall radiotherapy for breast cancer: Black, white and shades of grey

European Journal of Surgical Oncology

Volumn 36, Issue 4, 2010, Pages 331-334

  Kunkler, I ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

Adjuvant radiotherapy

Indexed keywords

BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER CONTROL; CANCER RECURRENCE; CANCER SURVIVAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; EDITORIAL; HUMAN; LYMPH NODE METASTASIS; MASTECTOMY; MEDICAL LITERATURE; OVERALL SURVIVAL; POSTOPERATIVE CARE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECURRENCE RISK; THORAX WALL;

AXILLA; BREAST NEOPLASMS; CLINICAL TRIALS AS TOPIC; COMBINED MODALITY THERAPY; FEMALE; HUMANS; LYMPHATIC METASTASIS; MASTECTOMY; RADIOTHERAPY, ADJUVANT; SURVIVAL ANALYSIS; THORACIC WALL;

EID: 77949267662     PISSN: 07487983     EISSN: 15322157     Source Type: Journal    
DOI: 10.1016/j.ejso.2009.11.004     Document Type: Editorial

References (33)

1. Ragaz J., Jackson S.M., Le N., et al. Adjuvant radiotherapy and chemotherapy in node-positive premenopausal women with breast cancer. N Engl J Med 337 (1997) 956-962
2. Overgaard M., Hansen P.S., Overgaard J., et al. Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. Danish Breast Cancer Cooperative Group 82b Trial. N Engl J Med 337 (1997) 949-955
3. Overgaard M., Jensen M.B., Overgaard J., et al. Randomised trial evaluating postoperative radiotherapy in high risk postmenopausal breast cancer patients given adjuvant tamoxifen. Results of the DBCG 82c trial. Lancet 353 (1999) 1043-1048
4. Paterson R., and Russell M.H. Clinical trials in malignant disease. Part III breast cancer: evaluation of postoperative radiotherapy. J Fac Radiol (London) 10 (1959) 17
5. Elston C.W., Gresham G.A., Rao G.S., et al. The cancer research campaign (King's/Cambridge trial for early breast cancer). Br J Cancer 45 (1982) 655-669
6. Kyndi M., Overgaard M., Nielsen H.M., et al. High local recurrence is not associated with large survival reduction after postmastectomy radiotherapy in high-risk breast cancer: a subgroup analysis of DBCG 82b&c. Radiother Oncol 90 (2009) 74-79
7. Cuzick J., Stewart H.J., Peto R., et al. Overview of randomised trials of postoperative radiotherapy in breast cancer. Cancer Treat Rep 1 (1987) 15-29
8. Levitt S.H., and Fletcher G.H. Trials and tribulations: do clinical trials prove that irradiation increases cardiac and secondary cancer mortality in the breast cancer patient?. Int J Rad Oncol Biol Phys 20 (1991) 523-527
9. Cuzick J., Stewart H.J., Rutqvist I., et al. Cause-specific mortality in longterm survivors of breast cancer who participated in trials of radiotherapy. J Clin Oncol 12 (1994) 1444-1455
10. Early Breast Cancer Trialists' Collaborative Group. Effects of radiotherapy and surgery in early breast cancer. An overview of the randomized trials. N Engl J Med 333 (1995) 1444-1455
11. Early Breast Cancer Trialists' Collaborative Group. Favourable and unfavourable effects on long-term survival of radiotherapy for early breast cancer: an overview of the randomised trials. Lancet 355 (2000) 1757-1770
12. Early Breast Cancer Trialists' Collaborative Group. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet 366 (2005) 2087-2106
13. Chung C.S., and Harris J.R. Post-mastectomy radiation therapy: translating local benefits into improved survival. Breast (2007) S78-S83
14. Hojris I., Overgaard M., Christensen J.J., et al. Morbidity and mortality of ischaemic heart disease in high-risk breast cancer patients after adjuvant postmastectomy systemic treatment with or without radiotherapy: analysis of DBCG 82b and 82c trials. Lancet 354 (1999) 1425-1430
15. Goldhirsch A., Coates A.S., Colleoni M., et al. Radiotherapy and chemotherapy in high risk breast cancer. N Engl J Med 338 (1998) 330-331
16. Recht A., Bartelink H., Fourquet A., et al. Postmastectomy radiotherapy: questions for the twenty-first century. J Clin Oncol 16 (1998) 2886-2889
17. Harris J., Halpin-Murphy P., McNeese M., et al. Consensus statement on postmastectomy radiation therapy. Int J Rad Oncol Biol Phys 44 (1999) 989-990
18. Recht A., Edge S., Solin L., et al. Postmastectomy radiotherapy guidelines of the American Society of clinical oncology. J Clin Oncol 19 (2001) 1539-1569
19. Goldhirsch A, Wood WC, Gelver RD et al. In: 10th St Gallen Conference. Progress and promise: highlights of the international expert consensus on the primary therapy of early breast cancer, vol. 18; 2007. p. 1133-44.
20. Marks L.B., Zeng J., and Prosnitz L.R. One to three versus four or more positive nodes and postmastectomy radiotherapy: time to end the debate. J Clin Oncol 26 (2008) 2075-2077
21. Russell N.S., Kunkler I.H., van Tienhoven G., et al. Postmastectomy radiotherapy: will the selective use of postmastectomy radiotherapy study end the debate?. J Clin Oncol 7 (2008) 996-997
22. Pierce L.J. The use of radiotherapy after mastectomy: a review of the literature. J Clin Oncol 8 (2005) 1706-1717
23. Ragaz J., Jackson S., Le N., et al. Survival gains of loco-regional radiation (RT) in breast cancer with 1-3 positive axillary nodes (N1-3): loco-regional recurrences (LocRecs) are NOT a useful guide to predict the benefit of RT- An update from the British Columbia (BC) randomised trial. Proc Am Soc Clin Oncol 19 (2000) 82a (abst 312)
24. Kunkler I.H., Canney P., van Tienhoven G., et al., On behalf of the MRC/EORTC (BIG 2-04) SUPREMO Trial Management Group. Elucidating the role of chest wall irradiation in 'Intermediate-risk' breast cancer: the MRC/EORTC SUPREMO trial. Clin Oncol 20 (2008) 31-34
25. Overgaard M., Nielsen H.M., Overgaard J., et al. Is the benefit of postmastectomy irradiation limited to patients with four or more positive nodes, as recommended in international consensus reports? A subgroup analysis of the DBCG 82b&c randomised trials. Radiother Oncol 82 (2007) 247-253
26. Poortmans P. Evidence based radiation oncology: breast cancer. Radiother Oncol 84 (2007) 84-101
27. Recht A., Gray R., Davidson N., et al. Loco-regional failure 10 years after mastectomy and adjuvant chemotherapy with or without tamoxifen without irradiation: experience of the Eastern Cooperative Oncology Group. J Clin Oncol 17 (1999) 1689-1700
28. Early and advanced breast cancer: diagnosis and treatment. NICE clinical guideline. NICE guideline 80 (February 2009), National Institute for Clinical Excellence, London p. 75
29. Kyndi M., Sorensen F.B., Knudsen H., et al. Estrogen receptor, progesterone receptor, HER-2 and response to postmastectomy radiotherapy in high-risk breast cancer: the Danish Breast Cancer Cooperative Group. J Clin Oncol 26 (2008) 1419-1426
30. Nuyten D.S., Kreike B., Hart A.A., et al. Predicting a local recurrence after breast-conserving therapy by gene expression profiling. Breast Cancer Res 8 (2006) R62
31. Yu J.B., Wilson L.D., Dasgupta T., et al. Postmastectomy radiation therapy for lymph node-negative, locally advanced breast cancer after modified radical mastectomy: analysis of the NCI surveillance, epidemiology, and end results database. Cancer 113 (2008) 38-47
32. Carlson R.W., Anderson B.O., Burnstein H.J., et al. NCCN breast cancer clinical practice guidelines in oncology. Version 1. Available at: (2007). http://www.nccn.org/professionals/physicians_gls/PDT/breast pdf
33. Ragaz J., Olivotto I.A., Spinelli J.J., et al. Locoregional radiation therapy in patients with high-risk breast cancer receiving adjuvant chemotherapy: 20-year results of the British Columbia randomized trial. J Natl Cancer Inst 97 (2005) 116-126